Hongbin Liu 30th Lorne Cancer Conference 2018

Abstracts this author is presenting:

• Epigenetic treatment-mediated modulation of PD-L1 predicts potential therapy resistance over response markers in myeloid malignancies: A molecular mechanism involving effectors of PD-L1 reverse signalling — Poster Session 2